| Title |
Palliative pharmacological sedation for terminally ill adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2015
|
| DOI | 10.1002/14651858.cd010206.pub2 |
| Pubmed ID | |
| Authors |
Elaine M Beller, Mieke L van Driel, Leanne McGregor, Shani Truong, Geoffrey Mitchell |
| Abstract |
Terminally ill people experience a variety of symptoms in the last hours and days of life, including delirium, agitation, anxiety, terminal restlessness, dyspnoea, pain, vomiting, and psychological and physical distress. In the terminal phase of life, these symptoms may become refractory, and unable to be controlled by supportive and palliative therapies specifically targeted to these symptoms. Palliative sedation therapy is one potential solution to providing relief from these refractory symptoms. Sedation in terminally ill people is intended to provide relief from refractory symptoms that are not controlled by other methods. Sedative drugs such as benzodiazepines are titrated to achieve the desired level of sedation; the level of sedation can be easily maintained and the effect is reversible. |
X Demographics
The data shown below were collected from the profiles of 145 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 28 | 19% |
| United States | 13 | 9% |
| Spain | 9 | 6% |
| Australia | 3 | 2% |
| Serbia | 3 | 2% |
| Canada | 3 | 2% |
| France | 3 | 2% |
| Ireland | 3 | 2% |
| Colombia | 2 | 1% |
| Other | 14 | 10% |
| Unknown | 64 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 99 | 68% |
| Practitioners (doctors, other healthcare professionals) | 32 | 22% |
| Scientists | 10 | 7% |
| Science communicators (journalists, bloggers, editors) | 4 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 446 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Hong Kong | 1 | <1% |
| United States | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 442 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 67 | 15% |
| Student > Bachelor | 48 | 11% |
| Researcher | 34 | 8% |
| Other | 30 | 7% |
| Student > Ph. D. Student | 29 | 7% |
| Other | 92 | 21% |
| Unknown | 146 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 153 | 34% |
| Nursing and Health Professions | 59 | 13% |
| Psychology | 23 | 5% |
| Social Sciences | 15 | 3% |
| Agricultural and Biological Sciences | 6 | 1% |
| Other | 41 | 9% |
| Unknown | 149 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 94. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2023.
All research outputs
#458,365
of 25,754,670 outputs
Outputs from Cochrane database of systematic reviews
#798
of 13,137 outputs
Outputs of similar age
#5,347
of 361,281 outputs
Outputs of similar age from Cochrane database of systematic reviews
#17
of 273 outputs
Altmetric has tracked 25,754,670 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,137 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,281 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.